Lianpeng Chang - Concepedia

Author

Lianpeng Chang

Annoroad Gene Technology (China)ORCID

Also Known As

Chang, Lianpeng, Chang, Linnan, L. Chang, L.-P. Chang, Lian-Peng Chang, Lianpeng Chang, Yanjun Zhang

106

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Annoroad Gene Technology (China)Chinese Academy of Medical Sciences & Peking Union Medical College The University of Texas MD Anderson Cancer Center Central South University Xi'an Jiaotong University

About

Lianpeng Chang is an author at Annoroad Gene Technology (China) specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	118
2	Pathology	5	5	118
3	Engineering	1	1	23
4	Health Sciences	1	1	24
5	Immunology	1	1	15

Lianpeng Chang

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study Jian-Ming Xu, Yun Zhang, Ru Jia, Clinical Cancer Research	2018	523
Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients Yongliang Zhang, Yu Yao, Yaping Xu, Nature Communications	2021	265
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer Jingying Nong, Yuhua Gong, Yanfang Guan, Nature Communications	2018	209
Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer Yan Wang, Chuanhua Zhao, Lianpeng Chang, EBioMedicine	2019	104
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma Minglei Zhuo, Yanfang Guan, Xue Yang, Clinical Cancer Research	2019	94
Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer Fei Ma, Yanfang Guan, Zongbi Yi, International Journal of Cancer	2019	88
CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors Yu Chen, Yingying Huang, Xuan Gao, Frontiers in Immunology	2020	78
Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic Profile Helei Hou, Hua Zhu, Han Zhao, The Oncologist	2018	77
Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance Zhe-Yu Hu, Ning Xie, Can Tian, EBioMedicine	2018	76
The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer Yaxiong Zhang, Lianpeng Chang, Yunpeng Yang, Journal for ImmunoTherapy of Cancer	2019	71

Page 1